DIC Market Influenced by Advancements in Automated Coagulation Analyzers
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Disseminated Intravascular Coagulation (DIC) Market In 2026, And How Will Its Value Evolve By 2030?
The disseminated intravascular coagulation (dic) market has demonstrated consistent growth in recent years. It is projected to expand from $0.49 billion in 2025 to $0.51 billion in 2026, at a compound annual growth rate (CAGR) of 5.0%. The historical growth can be attributed to factors such as high mortality in critical care, limited early diagnostic tools, sepsis prevalence, trauma-related complications, and a lack of targeted therapies.
The disseminated intravascular coagulation (dic) market is projected to experience consistent expansion over the upcoming years. By 2030, its value is anticipated to reach $0.61 billion, exhibiting a compound annual growth rate (CAGR) of 4.8%. This anticipated growth during the forecast period is driven by factors such as enhanced coagulation diagnostics, better critical care facilities, proactive intervention strategies, progress in clinical research, and various awareness initiatives. Key trends during the same period are expected to encompass a heightened emphasis on the early detection of coagulation disorders, an increasing adoption of blood component therapies, the expansion of critical care services within hospitals, greater understanding of dic in vulnerable populations, and the implementation of sophisticated diagnostic monitoring instruments.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Important Drivers Are Guiding The Disseminated Intravascular Coagulation (DIC) Market Growth?
The rising occurrence of cancer is projected to propel the expansion of the disseminated intravascular coagulation (DIC) market in the future. Cancer is defined as an illness marked by the unchecked multiplication and dissemination of atypical cells within the body, capable of infiltrating and damaging healthy tissues. The increase in cancer diagnoses is attributed to elements like an aging demographic, shifts in lifestyle, exposure to environmental factors, various infections, and inherited susceptibilities. Cancer has the potential to induce disseminated intravascular coagulation (DIC) by initiating an over-activation of the coagulation cascade via procoagulant substances generated by tumors, resulting in extensive clotting alongside bleeding. As an illustration, information from May 2024, sourced from the National Cancer Institute, a US-based government agency, indicated that in 2022, roughly 20 million new cancer cases and 9.7 million deaths linked to cancer were documented globally. Forecasts anticipate that these figures might rise to 29.9 million new cases and 15.3 million deaths annually by 2040. Consequently, the expanding incidence of cancer is fueling the growth of the disseminated intravascular coagulation (DIC) market.
How Are Different Segments Classified In The Disseminated Intravascular Coagulation (DIC) Market Segment Analysis?
The disseminated intravascular coagulation (dic) market covered in this report is segmented –
1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy
What Trends Are Influencing The Evolution Of The Disseminated Intravascular Coagulation (DIC) Market?
Leading companies operating within the disseminated intravascular coagulation (DIC) market are focusing on utilizing advanced solutions, such as real-time hemostasis monitoring, to enhance the speed, accuracy, and intervention capabilities in diagnosing and treating critically ill patients. Real-time hemostasis monitoring involves the continuous assessment of clot formation and coagulation parameters during testing, thereby offering clinicians timely insights for improved management of coagulopathy. For example, in February 2024, Roche Diagnostics, an in vitro diagnostics company based in Switzerland, introduced three new coagulation assays for Factor Xa inhibitors (apixaban, edoxaban, and rivaroxaban) on its cobas t line of automated analyzers. These assays employ Roche’s cassette-based reagent system, which standardizes reagent preparation, minimizes manual handling, and provides rapid, reliable anti-Xa activity measurement, essential for managing DIC patients who are receiving anticoagulants.
Who Are The Companies Driving Activity In The Disseminated Intravascular Coagulation (DIC) Market?
Major companies operating in the disseminated intravascular coagulation (dic) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Abbott Laboratories, Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Siemens Healthineers, Grifols S.A., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Novartis AG, Eli Lilly and Company, GlaxoSmithKline plc
Get The Full Disseminated Intravascular Coagulation (DIC) Market Report:
Where Is The Disseminated Intravascular Coagulation (DIC) Market Most Concentrated Geographically?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2025. The regions covered in the disseminated intravascular coagulation (dic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Disseminated Intravascular Coagulation (DIC) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Disseminated Intravascular Coagulation (DIC) Market 2026, By The Business Research Company
Deep Vein Thrombosis Market Report 2026
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report
Anticoagulant Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report
Point Of Care Poc Coagulation Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
